Sleuth

Name: Sleuth
Brand: Sleuth
Rating: 4.6 (46 reviews)

AI Native

Done-for-you biopharma decision intelligence

Est 2023|Valuation $31M|Raised $7.7M|4 Ref Customers

LinkedIn 4K|Web traffic 2K|FTEs 18|HQ San Francisco, California, US

MarketsMarket Intelligence

01Competitive Landscape

Narrative analysis

- Direct competitors and their key differentiators - Clarivate Cortellis: differentiates on breadth of established life sciences content, analyst coverage, and entrenched adoption in some large organizations. - Citeline: strong in clinical trial intelligence and operational trial planning, with products focused on Trialtrove and Pharmaprojects. - Evaluate / Norstella: commonly used for forecasting and portfolio analytics; often referenced for revenue/consensus forecasting capabilities. - AlphaSense: not biopharma-specific but widely used for searching and synthesizing market intelligence across industries. - Feature comparison: where Sleuth may differ from incumbents - Areas where the vendor claims differentiation: - Synthesis into narrative deliverables with traceable sources. - Knowledge-graph grounding for relationships between entities. - Handling of certain non-traditional or less-standardized sources. - Areas where incumbents may have advantages: - Long-established, large datasets and standardized taxonomies. - Depth in forecasting and operational trial planning in specific products. - Pricing comparison: value proposition vs alternatives - Most competitors use quote-based enterprise pricing, which makes direct price comparisons difficult without proposals. - Customer testimonials comparing Sleuth to competitors - No high-signal public quotes were found that directly compare Sleuth Insights to incumbents such as Cortellis, Citeline, or Evaluate. - Market share and adoption trends - No reliable market share data for Sleuth Insights was found in publicly accessible sources. - When customers choose competitors instead (and why) - Likely reasons (to be validated via customer references): existing enterprise standardization on incumbent platforms, requirements for forecasting consensus data, or procurement/security requirements favoring established vendors.

	Sleuth (vendor website)	Clarivate Cortellis	Citeline (Pharmaprojects/Trialtrove)
Starting Price	Not publicly disclosed (vendor-reported licensing model)	Not publicly disclosed (enterprise/quote-based pricing)	Not publicly disclosed (enterprise/quote-based pricing)
Primary Use Cases	Strategy/BD/CI teams seeking traceable narrative outputs and integrated research workflows	Large life sciences organizations needing a broad, established intelligence suite across pipelines, deals, and analytics	Teams requiring deep pipeline and clinical trial intelligence datasets and operational trial planning support
Key Strengths	Knowledge-graph based answers with source traceability (vendor stated); integrated research outputs and managed analyst support options	Broad, long-established datasets and recognized brand presence in life sciences intelligence	Extensive trial and pipeline datasets; strong coverage across registries and curated clinical sources
Key Weaknesses	Limited publicly available customer reviews and procurement documentation; pricing and some security details not public	Cost and complexity; procurement burden for large suites; potential for product overlap within the suite	Cost and learning curve; some functionality distributed across multiple modules requiring multiple procurements

01Competitive Landscape

Narrative analysis

Direct competitors and their key differentiators
- Clarivate Cortellis: differentiates on breadth of established life sciences content, analyst coverage, and entrenched adoption in some large organizations.
- Citeline: strong in clinical trial intelligence and operational trial planning, with products focused on Trialtrove and Pharmaprojects.
- Evaluate / Norstella: commonly used for forecasting and portfolio analytics; often referenced for revenue/consensus forecasting capabilities.
- AlphaSense: not biopharma-specific but widely used for searching and synthesizing market intelligence across industries.
Feature comparison: where Sleuth may differ from incumbents
- Areas where the vendor claims differentiation:
  - Synthesis into narrative deliverables with traceable sources.
  - Knowledge-graph grounding for relationships between entities.
  - Handling of certain non-traditional or less-standardized sources.
- Areas where incumbents may have advantages:
  - Long-established, large datasets and standardized taxonomies.
  - Depth in forecasting and operational trial planning in specific products.
Pricing comparison: value proposition vs alternatives
- Most competitors use quote-based enterprise pricing, which makes direct price comparisons difficult without proposals.
Customer testimonials comparing Sleuth to competitors
- No high-signal public quotes were found that directly compare Sleuth Insights to incumbents such as Cortellis, Citeline, or Evaluate.
Market share and adoption trends
- No reliable market share data for Sleuth Insights was found in publicly accessible sources.
When customers choose competitors instead (and why)
- Likely reasons (to be validated via customer references): existing enterprise standardization on incumbent platforms, requirements for forecasting consensus data, or procurement/security requirements favoring established vendors.

	Sleuth (vendor website)	Clarivate Cortellis	Citeline (Pharmaprojects/Trialtrove)
Starting Price	Not publicly disclosed (vendor-reported licensing model)	Not publicly disclosed (enterprise/quote-based pricing)	Not publicly disclosed (enterprise/quote-based pricing)
Primary Use Cases	Strategy/BD/CI teams seeking traceable narrative outputs and integrated research workflows	Large life sciences organizations needing a broad, established intelligence suite across pipelines, deals, and analytics	Teams requiring deep pipeline and clinical trial intelligence datasets and operational trial planning support
Key Strengths	Knowledge-graph based answers with source traceability (vendor stated); integrated research outputs and managed analyst support options	Broad, long-established datasets and recognized brand presence in life sciences intelligence	Extensive trial and pipeline datasets; strong coverage across registries and curated clinical sources
Key Weaknesses	Limited publicly available customer reviews and procurement documentation; pricing and some security details not public	Cost and complexity; procurement burden for large suites; potential for product overlap within the suite	Cost and learning curve; some functionality distributed across multiple modules requiring multiple procurements